Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

OXPAT Mouse anti-Human, Clone: OTI3F2, Invitrogen™

Mouse Monoclonal Antibody

Manufacturer:  Invitrogen MA527505

Catalog No. PIMA527505


Add to cart

Description

Description

OXPAT is a novel PAT-1 protein that is expressed in highly oxidative tissues. Lipid droplet proteins of the PAT family regulate cellular neutral lipid stores. OXPAT is induced by physiological (fasting), pathophysiological (insulin deficiency), pharmacological (peroxisome proliferator-activated receptor [PPAR] agonists), and genetic (muscle-specific PPAR alpha overexpression) disturbances that increase fatty acid utilization. It is suggested that OXPAT is a marker for PPAR activation and fatty acid oxidation. As well, it may contribute to adaptive responses to the fatty acid responsibility that accompanies fasting, insulin deficiency, and overnutrition, responses that are defective in obesity and type 2 diabetes.
Specifications

Specifications

OXPAT
Monoclonal
1 mg/mL
PBS with 1% BSA, 50% glycerol and 0.02% sodium azide; pH 7.3
Q00G26
LSDA5, LSDP5, MLDP, PLIN5, PAT-1, Lipid droplet-associated protein PAT-1
Mouse
IgG1
100 μL
-20° C, Avoid Freeze/Thaw Cycles
Primary
440503
Immunohistochemistry (Paraffin), Western Blot
OTI3F2
Unconjugated
PLIN5
Liquid
PLIN5
Human recombit protein fragment corresponding to amino acids 1-463 of PLIN5 produced in E.coli
Affinity Chromatography
RUO
Antibody
Monoclonal
Human
Documents
Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit